Precision Medicine 2020:
|Time||Topic & Speaker(s)|
|10:00–10:05 AM||Welcome — Isaac Kohane, DBMI Chair, Harvard Medical School|
|10:05–10:20 AM||Opening Remarks — George Daley, Dean, Harvard Medical School|
|10:20–10:30 AM||Introduction — Isaac Kohane|
|10:30–11:00 AM||Keynote Address — Julia Vitarello, Mila’s Miracle Foundation|
|11:10 AM – 12:00 PM||PANEL 1 — How do we scale up? What is the path to industrialization?
|12:00–12:10 PM||PAUSE FOR REFLECTION — Brief remarks and 8'46" silence to focus on racial equity and inclusivity|
|12:10–12:40 PM||Fireside Chat – Amy Abernethy, Principal Deputy Commissioner and Acting Chief Information Officer, FDA|
|12:40–1:00 PM||LUNCH BREAK|
|1:00–1:50 PM||PANEL 2 — How do we decide who to treat?
|2:00–2:50 PM||PANEL 3 — Is there a role for hyperindividualized therapy in common diseases?
|3:00–3:50 PM||PANEL 4 — COVID-19 Therapeutics
|3:50–4:00 PM||Closing Remarks — Isaac Kohane|
Conference sponsored by DBMI, Merck, and Medidata
What do we mean by “precision medicine”? From the perspective of one of the members of the National Academy of Sciences committee that wrote the report, we mean taking an explicit multidimensional view of patients: not just one data modality such as genomics or environmental exposure. We argue that this perspective allows for more precise matching of humans to disease states (diagnosis), future disease states (prognosis) and appropriate therapies.